Orchid Pharma Ltd has entered into a long-term financial agreement to avail up to $800 million as loan from Line Trust International of the UK to explore new growth opportunities.
In a filing to BSE, Chennai-based Orchid Pharma said its wholly-owned subsidiary Orchid Europe Ltd “has entered into a long-term financial arrangement to avail up to $800 million as loan with Line Trust International, Guernsey, UK.”
